迟发性皮肤卟啉病一例报告
摘要
<正>迟发性皮肤卟啉病(porphyria cutanea tarda,PCT)是由于尿卟啉增多而产生的最常见的一种皮肤型卟啉病。以光敏性皮疹、皮肤脆性增加为本病主要特点。本研究对1例卟啉病患者进行报告。1病例报告患者男,48岁,工人。因头面、双手水疱结痂约6个月入院。素体健康,喜饮酒,否认肝炎、肺结核等传染病史,否认糖尿病、高血压、心脏病及肾病病史,否认家族
引文
[1]朱旭利,陈云锦.迟发性皮肤卟啉病1例[J].实用医学杂志,2011,27(8):1455.
[2]赵辩.中国临床皮病病学[M].第2版.南京:江苏凤凰科学技术出版社,2017:1557-1559.
[3]Chiavérini C,Halimi G,Ouzan D,et al.Porphyria cutanea tarda,C282Y,H63Dand S65CHFE gene mutations and hepatitis C infection:A study from southern France[J].Dermatology,2003,206(3):212-216.
[4]Dereure O,Aguilar-Martinez P,Bessis D,et al.HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda:aprospective study of 36cases from southern France[J].Br J Dermatol,2001,144(3):533-539.
[5]Lamoril J,Andant C,Gouya L,et al.Hemochromatosis(HFE)and transferrin receptor-1(TFRC1)genes in sporatic porphyria cutanea tarda(sPCT)[J].Cell Mol Biol(Noisy-le-grand),2002,48(1):33-41.
[6]McManus JF,Begley CG,Sassa S,et al.Five new mutations in the uroporphyrinogen decarboxylase gene identified in families with cutaneous porphyria[J].Blood,1996,88(9):3589-3600.
[7]Pandya AG,Nezafati KA,Ashe-Randolph M,et al.Deferasirox for porphyria cutanea tarda:A pilot study[J].Arch Dermatol,2012,148(8):898-901.
[2]赵辩.中国临床皮病病学[M].第2版.南京:江苏凤凰科学技术出版社,2017:1557-1559.
[3]Chiavérini C,Halimi G,Ouzan D,et al.Porphyria cutanea tarda,C282Y,H63Dand S65CHFE gene mutations and hepatitis C infection:A study from southern France[J].Dermatology,2003,206(3):212-216.
[4]Dereure O,Aguilar-Martinez P,Bessis D,et al.HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda:aprospective study of 36cases from southern France[J].Br J Dermatol,2001,144(3):533-539.
[5]Lamoril J,Andant C,Gouya L,et al.Hemochromatosis(HFE)and transferrin receptor-1(TFRC1)genes in sporatic porphyria cutanea tarda(sPCT)[J].Cell Mol Biol(Noisy-le-grand),2002,48(1):33-41.
[6]McManus JF,Begley CG,Sassa S,et al.Five new mutations in the uroporphyrinogen decarboxylase gene identified in families with cutaneous porphyria[J].Blood,1996,88(9):3589-3600.
[7]Pandya AG,Nezafati KA,Ashe-Randolph M,et al.Deferasirox for porphyria cutanea tarda:A pilot study[J].Arch Dermatol,2012,148(8):898-901.